
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered ... Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all class I isoforms of PI3K and mammalian target of rapamycin (mTOR). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.87 | 22.3416965352 | 8.37 | 10.48 | 8.13 | 204178 | 9.50493727 | CS |
4 | -0.14 | -1.34874759152 | 10.38 | 11.17 | 7.575 | 388194 | 9.43014738 | CS |
12 | -1.3 | -11.2651646447 | 11.54 | 13.425 | 7.575 | 282162 | 10.28293108 | CS |
26 | -5.7 | -35.7590966123 | 15.94 | 16.5431 | 7.575 | 277916 | 11.81464935 | CS |
52 | -6.92 | -40.3263403263 | 17.16 | 19.77 | 7.575 | 299044 | 14.25970125 | CS |
156 | 2.31 | 29.1298865069 | 7.93 | 22.188 | 4.81 | 161114 | 13.6239477 | CS |
260 | 5.95 | 138.694638695 | 4.29 | 33.01 | 4.13 | 130405 | 15.48056049 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions